Also trades as: GEDSF (OTC) · $vol 0M

$38.36

-0.04 (-0.11%)

Weekly Expected Move ±5.1%

$34 $36 $38 $40 $42

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 44 · $7.0B mcap · 133M float · 0.0007% daily turnover · Short 74% of daily vol

Revenue

$929.0B +8.3% ▲

5Y CAGR: +10.4%

Gross Profit

$640.9B +8.5% ▲

5Y CAGR: +15.3%

Operating Income

$323.7B +26.4% ▲

5Y CAGR: +20.6%

Net Income

$232.3B -2.9% ▼

5Y CAGR: +17.3%

EPS (Diluted)

$1271.00 -2.8% ▼

5Y CAGR: +17.7%

EBITDA

$323.7B -3.5% ▼

5Y CAGR: +15.9%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$630.6B	$802.8B	$805.2B	$857.5B	$929.0B
YoY Growth	+11.3%	+27.3%	+0.3%	+6.5%	+8.3%
Cost of Revenue	$281.3B	$342.3B	$283.8B	$266.8B	$288.1B
Gross Profit	$349.3B	$460.5B	$521.3B	$590.7B	$640.9B
Gross Margin	55.4%	57.4%	64.7%	68.9%	69.0%
R&D Expenses	$61.0B	$75.1B	$78.3B	$99.2B	$0
SG&A Expenses	$143.3B	$182.3B	$196.6B	$221.0B	$222.8B
Operating Expenses	$209.5B	$292.0B	$332.0B	$334.6B	$317.2B
Operating Income	$139.8B	$168.5B	$189.4B	$256.2B	$323.7B
Operating Margin	22.2%	21.0%	23.5%	29.9%	34.8%
Interest Expense	$663M	$8.0B	$15.3B	$65.5B	$79.0B
Income Before Tax	$146.6B	$165.7B	$171.5B	$281.1B	$284.7B
Tax Expense	$5.4B	-$5.1B	$10.9B	$41.6B	$52.5B
Net Income	$139.6B	$169.1B	$158.8B	$239.2B	$232.3B
Net Margin	22.1%	21.1%	19.7%	27.9%	25.0%
EPS (Diluted)	$750.65	$907.39	$859.72	$1307.00	$1271.00
EBITDA	$175.6B	$233.6B	$262.6B	$335.5B	$323.7B
Shares Outstanding	186M	186M	185M	183M	183M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$216.7B	$221.1B	$224.0B	$241.5B	$214.7B	$247.3B	$219.8B	$237.6B
Cost of Revenue	$69.1B	$70.0B	$68.9B	$80.9B	$71.3B	$75.1B	$72.3B	$71.2B
Gross Profit	$147.7B	$151.1B	$155.2B	$160.6B	$143.4B	$172.2B	$147.5B	$166.4B
Gross Margin	68.1%	68.3%	69.3%	66.5%	66.8%	69.6%	67.1%	70.0%
R&D Expenses	$24.9B	$29.0B	$23.8B	$25.1B	$19.5B	$22.7B	$22.8B	$22.5B
SG&A Expenses	$51.1B	$62.3B	$59.2B	$59.0B	$52.3B	$52.0B	$55.2B	$56.8B
Operating Expenses	$76.8B	$91.4B	$87.4B	$88.0B	$71.7B	$76.3B	$76.6B	$79.4B
Operating Income	$70.9B	$59.7B	$67.8B	$72.6B	$71.6B	$95.8B	$70.9B	$86.9B
Operating Margin	32.7%	27.0%	30.2%	30.1%	33.4%	38.8%	32.3%	36.6%
Interest Expense	$27.7B	$29.7B	$41.0B	$5.3B	$13.1B	$19.5B	$15.6B	$49.1B
Income Before Tax	$45.9B	$78.6B	$82.0B	$63.1B	$52.1B	$87.1B	$78.6B	$45.2B
Tax Expense	$8.8B	$14.9B	$13.8B	$11.1B	$8.7B	$18.8B	$13.3B	$7.7B
Net Income	$37.1B	$64.0B	$68.1B	$51.8B	$43.3B	$68.6B	$65.2B	$37.7B
Net Margin	17.1%	28.9%	30.4%	21.5%	20.2%	27.7%	29.6%	15.9%
EPS (Diluted)	$203.00	$348.00	$373.00	$283.23	$236.85	$376.52	$357.22	$206.57
EBITDA	$108.2B	$121.0B	$81.8B	$85.5B	$79.7B	$111.9B	$87.0B	$100.9B
Shares Outstanding	183M	184M	183M	183M	183M	183M	182M	183M

RGEDF OTC